F.L. Putnam Investment Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$697K Sell
231,405
-49,499
-18% -$140K 0.01% 418
2026
Q1
$680K Sell
280,904
-22,410
-7% -$61.1K 0.01% 375
2025
Q4
$1.32M Buy
303,314
+3,024
+1% +$16.3K 0.02% 299
2025
Q3
$1.26M Buy
300,290
+263,131
+708% +$935K 0.02% 309
2025
Q2
$107K Buy
+37,159
New +$98.2K ﹤0.01% 572

Other funds holding GNLX

F.L. Putnam Investment Management's GNLX Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its Genelux (GNLX) stake by 18% in Q2 2026, selling an estimated $140K and leaving 231,405 shares worth $697K. The position accounts for 0.01% of the portfolio, ranked #418.

F.L. Putnam Investment Management first reported a position in GNLX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.32M in Q4 2025. 38 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • F.L. Putnam Investment Management held 231,405 shares of Genelux worth $697K as of Q2 2026.
  • F.L. Putnam Investment Management sold 49,499 Genelux shares in Q2 2026, an estimated $140K.
  • Genelux made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #418 holding.
  • F.L. Putnam Investment Management first reported a position in Genelux in Q2 2025 and has held it in 5 quarters since.
  • F.L. Putnam Investment Management's Genelux position peaked at $1.32M in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.